These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33478193)

  • 41. HDAC Overexpression in a NUT Midline Carcinoma of the Parotid Gland with Exceptional Survival: A Case Report.
    Esteves G; Ferreira J; Afonso R; Martins C; Zagalo C; Félix A
    Head Neck Pathol; 2020 Dec; 14(4):1117-1122. PubMed ID: 31989434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.
    French CA; Miyoshi I; Kubonishi I; Grier HE; Perez-Atayde AR; Fletcher JA
    Cancer Res; 2003 Jan; 63(2):304-7. PubMed ID: 12543779
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma.
    Lee JK; Louzada S; An Y; Kim SY; Kim S; Youk J; Park S; Koo SH; Keam B; Jeon YK; Ku JL; Yang F; Kim TM; Ju YS
    Ann Oncol; 2017 Apr; 28(4):890-897. PubMed ID: 28203693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical features, treatment, and survival outcome of primary pulmonary NUT midline carcinoma.
    Xie XH; Wang LQ; Qin YY; Lin XQ; Xie ZH; Liu M; Zhang JX; Ouyang M; Liu J; Gu YY; Li SY; Zhou CZ
    Orphanet J Rare Dis; 2020 Jul; 15(1):183. PubMed ID: 32650830
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathologic characteristics of NUT midline carcinoma arising in the mediastinum.
    Evans AG; French CA; Cameron MJ; Fletcher CD; Jackman DM; Lathan CS; Sholl LM
    Am J Surg Pathol; 2012 Aug; 36(8):1222-7. PubMed ID: 22790861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An Overview of Molecular Mechanism, Clinicopathological Factors, and Treatment in NUT Carcinoma.
    Huang QW; He LJ; Zheng S; Liu T; Peng BN
    Biomed Res Int; 2019; 2019():1018439. PubMed ID: 31815119
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic significance and cytological features of NUT carcinoma by EBUS-FNA, a case report and literature review.
    Ju Y; Velazquez M; Sherrod A; Wang T
    Cytopathology; 2024 Jul; 35(4):497-502. PubMed ID: 38551146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NUT midline carcinoma as a primary lung tumor treated with anlotinib combined with palliative radiotherapy: a case report.
    Jiang J; Ren Y; Xu C; Lin X
    Diagn Pathol; 2022 Jan; 17(1):4. PubMed ID: 34996489
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytomorphology of primary pulmonary NUT carcinoma in different cytology preparations.
    Dutta R; Nambirajan A; Mittal S; Roy-Chowdhuri S; Jain D
    Cancer Cytopathol; 2021 Jan; 129(1):53-61. PubMed ID: 32877005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinicopathological and molecular characterizations of pulmonary NUT midline carcinoma.
    Xie M; Fu X; Wang W
    Cancer Med; 2021 Sep; 10(17):5757-5764. PubMed ID: 34409758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sinonasal NUT midline carcinoma: A new histological entity.
    Vakani PN; Maheshwari J; Maheshwari M; Shah B
    Indian J Pathol Microbiol; 2020; 63(1):103-105. PubMed ID: 32031134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The cytologic features of NUT midline carcinoma.
    Bellizzi AM; Bruzzi C; French CA; Stelow EB
    Cancer; 2009 Dec; 117(6):508-15. PubMed ID: 19795508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary malignant epithelioid and rhabdoid tumor of bone harboring ZNF532-NUTM1 fusion: the expanding NUT cancer family.
    Chien YW; Hsieh TH; Chu PY; Hsieh SM; Liu ML; Lee JC; Liu YR; Ku JW; Kao YC
    Genes Chromosomes Cancer; 2019 Nov; 58(11):809-814. PubMed ID: 31334571
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinicopathological features in young patients treated for small-cell lung cancer: significance of immunohistological and molecular analyses.
    Taniyama TK; Nokihara H; Tsuta K; Horinouchi H; Kanda S; Fujiwara Y; Yamamoto N; Koizumi F; Yunokawa M; Tamura T
    Clin Lung Cancer; 2014 May; 15(3):244-7. PubMed ID: 24456892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NUT midline carcinoma: an aggressive intrathoracic neoplasm.
    Parikh SA; French CA; Costello BA; Marks RS; Dronca RS; Nerby CL; Roden AC; Peddareddigari VG; Hilton J; Shapiro GI; Molina JR
    J Thorac Oncol; 2013 Oct; 8(10):1335-8. PubMed ID: 24457244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Staging and evaluation of neoadjuvant chemotherapy response with ¹⁸F-FDG PET/CT in NUT-midline carcinoma in a child: a case report and review of the literature.
    Ciftci E; Demirsoy U; Anik Y; Gorur G; Corapcioglu F; Demir H
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):53-5. PubMed ID: 25304847
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NUT carcinoma of the thorax: Case report and review of the literature.
    Harms A; Herpel E; Pfarr N; Penzel R; Heussel CP; Herth FJ; Dienemann H; Weichert W; Warth A
    Lung Cancer; 2015 Dec; 90(3):484-91. PubMed ID: 26490121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody.
    Haack H; Johnson LA; Fry CJ; Crosby K; Polakiewicz RD; Stelow EB; Hong SM; Schwartz BE; Cameron MJ; Rubin MA; Chang MC; Aster JC; French CA
    Am J Surg Pathol; 2009 Jul; 33(7):984-91. PubMed ID: 19363441
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NUT midline carcinoma: an imaging case series and review of literature.
    Polsani A; Braithwaite KA; Alazraki AL; Abramowsky C; Shehata BM
    Pediatr Radiol; 2012 Feb; 42(2):205-10. PubMed ID: 22033856
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NUT midline carcinomas of the sinonasal tract.
    Bishop JA; Westra WH
    Am J Surg Pathol; 2012 Aug; 36(8):1216-21. PubMed ID: 22534723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.